5-Morpholin-4-yl-1,3,4-oxadiazol-2-ylamine, 95.0%, 250mg

Methyl 2-fluoro-5-methyl-3-nitrobenzoate, 97%, 250mg

5-Fluoro-6-methoxy-2,3-dihydro-1H-inden-1-amine, 98%, 100mg

Methyl 4-bromo-5-chloropicolinate, 97%, 100mg

2,6-Dihydroxyacétophénone, min 98%, 5 g, emballage plastique.

1-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 95.0%, 500mg

Methyl1-methylpyrrolo[2,3-b]pyridine-6-carboxylate, 98%, 500mg

N,N,N-Trimethylbutan-1-aminium chloride, 95.0%, 5g

Tetramethyl cis,trans,cis-1,2,3,4-Cyclobutanetetracarboxylate>98.0%(GC)5g

3'-Cyano-2,2,2-trifluoroacetophenone, 95.0%, 1g

4-Amino-5-bromo-2-chloropyrimidine, 95.0%, 10g

(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline, 98.0%, 10g

6-Bromo-1,4-benzodioxane>98.0%(T)5g